Home›Companies›Biotech & Pharma›Spear Bio

Spear Bio Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 5, 2024·Suggest an edit

About Spear Bio

Spear Bio is a private company based in Woburn, Massachusetts, incorporated in 2021 in Delaware. It has reported $50,062,614 raised in four offerings on Form D since March 2021. Its chief executive is Feng Xuan.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 23, 2024Aug 5, 2024$44,999,997fully sold8$5.6MEquityRule 506(b)Form D ↗
Oct 11, 2022Oct 18, 2022$2,391,188of $3.0M target5$478KEquity, Debt, Securities on exercise, Convertible Promissory NotesRule 506(b)Form D ↗
Sep 30, 2021Oct 14, 2021$1,571,429of $10.0M target3$523KDebt, Securities on exerciseRule 506(b)Form D ↗
Mar 15, 2021Mar 26, 2021$1,100,000of $1.2M target4$275KEquity, OptionsRule 506(b)Form D ↗
Total, four offerings$50,062,614

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Spear Bio's Form D filed Aug 5, 2024.

FX
Feng Xuan
Chief Executive Officer and director
JW
John Wu
Executive officer
DS
David Singer
Director
PY
Peng Yin
Director
WC
Wen Chan
Director
VB
Vikram Bajaj
Director

Earlier filings also listed Jerome Clavel (executive officer and director, last listed Oct 2022) and Michael Natan (president and ceo, director, last listed Oct 2021).

Sources

  1. SECSpear Bio Inc. filing history